Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
--------
Question: Paragraph: The power crisis is affecting health and sanitation - because sewage treatment plants can’t run, raw sewage is pouring into the Mediterranean - and now the elderly and sick are desperately trying to handle the heat. Plastic trays and scraps of cardboard are doubling as hand-held fans. Precious piped water is hosed over children and work animals. Those trying to sleep have abandoned clammy mattresses, preferring the relative cool of bare tiled floors. Hoping to pressure the Islamist Hamas group to relinquish control of Gaza, Palestinian President Mahmoud Abbas has reduced his administration’s payments to Israel for the electricity it supplies to Gaza. That has left the 2 million Palestinians there with only a few hours of power a day. Hospitals and other emergency facilities have made do with back-up generators. Few ordinary Palestinians have that option. A family excursion to the beach that might elsewhere have been a delight was, for Sabah Joudah, a forced decision, especially when having to put up with the sewage problems. “We came here to entertain the children, even though the sea is polluted,” she told Reuters as the dirty surf lapped close by. “It is summer and there is no electricity; no water and no fans are working in our homes. It is very tough, very tough.”   Environment officials say disruptions at sewage treatment facilities have meant more than 100,000 liters of untreated wastewater is discharged along the coast daily. Around 75 percent of the seawater is polluted. Swimming there frequently leaves children with skin inflammations and abdominal complaints, parents say. In the southern town of Khan Younis, a woman bathed her children in a bucket in the street, while a man doused his horse with water. One Khan Younis couple, the Abu Mehsens, both suffer from high blood pressure and said they were so beleaguered by the heat that simply fanning themselves could be too much effort. “When we get tired we rest for a bit before we start fanning again,” Jihan Abu Mehsen said. “We do so all day long.”    The situation has hurt Gaza’s meager retail sector, with vendors saying that sales of electrical appliances have tanked. One exception has been cheap rechargeable fans, which can be stored, with full batteries, in anticipation of the power cuts. “People have turned to alternative power, using batteries,” said appliance salesman Mahmoud Abu Hamda. “Sometimes they use trays and sometimes even the covers of kettles instead of electric fans. This has impacted us very much.” Claim: As temperatures soar, desperate Gazans try any means to beat heat.

Answer: As Middle East summer temperatures soar above 35 degrees Celsius (95 Fahrenheit), Gazans are struggling to stay cool amid a power crisis, with less than four hours of electricity a day and little chance to run fans and air-conditioners.


Question: Paragraph: The nation saw one of the worst flu outbreaks in nearly a decade during the 2017-2018 season, with more than 900,000 cases of hospitalizations and over 80,000 deaths, the CDC estimates here  Between Oct. 1, 2018 and Jan. 5, 2019, about 6 million to 7 million people were reported to have contracted the flu, according to data collected by the health agency. Health regulators have been trying to combat flu outbreaks in the United States and the U.S. Food and Drug Administration approved the first new flu medication in nearly two decades last year. The CDC last month signaled the start of the flu season (click here), saying that 24 states and Guam were reporting widespread cases, with the H1N1 virus being the predominant strain. The dominant flu strain during the last season, H3N2, has been linked with severe disease and death, particularly among children and the elderly. The agency continues to recommend vaccination as the best way to reduce the risk of flu and advised people who are at high risk category to approach hospital for treatment with a flu antiviral drug. Claim: Up to 84,000 Americans hospitalized with flu in past three months: CDC.

Answer: An estimated 69,000 to 84,000 Americans were hospitalized due to the flu in the last three months, the Centers for Disease Control and Prevention (CDC) said on Friday.


Question: Paragraph: A study conducted by the University of California, Irvine,  also found that the drug combination was much less toxic than  chemotherapy. “I think we are on track to develop a medical means to  prevent colon cancer,” in people at high risk of developing the  disease, said Dr. Frank Meyskens, director of the university’s  cancer center. He said earlier efforts to develop a preventive  treatment were thwarted by the fact that available therapies  caused too much toxicity. Meyskens lead a study in which 375 patients with at least  one previous colorectal polyp, also known as adenomas, were  treated with either a combination of one-time cancer drug DFMO  (difluoromethylornithine) and sulindac, a non-steroidal  anti-inflammatory drug (NSAID), or placebo. The results, presented at a meeting of the American  Association for Cancer Research in San Diego, were so  encouraging that the study was stopped early. After three years, the overall risk of recurrent adenoma  was 12.3 percent in treated patients, compared with 41.1  percent for patients in the placebo group, or a 70 percent risk  reduction. For patients with more than one previous polyp, 0.7 percent  of treated patients had a recurrence, compared with 13.2  percent of placebo patients — a 95 percent reduction. The researchers said an analysis of side effects and  toxicity found no difference between the treatment and placebo  groups. There also was no difference in side effects requiring  overnight hospitalization, gastrointestinal side effects or  cardiovascular side effects between the two groups. DFMO is the basis of the drug eflornithine, which was  initially developed as a cancer medication, but is now used to  treat African sleeping sickness. A cream formulation of  eflornithine is marketed as a hair removal agent under the  brand name Vaniqa. Sulindac is sold by Merck & Co Ltd under the brand name  Clinoril as a treatment for arthritis and other inflammatory  conditions. Meyskens said larger trials will be needed to assess the  risk of cardiovascular and other adverse side effects, as well  as to determine whether the incidence of actual colorectal  cancer can be reduced in either patients with low stage prior  colorectal cancers or in very high risk individuals. Chronic use of other NSAIDs, such as Merck’s Vioxx, has  been linked to an increased risk of heart attack and stroke. Sulindac is associated with liver toxicity. A separate large study presented at the conference showed  that Pfizer Inc’s Cox-2 inhibitor Celebrex, or celecoxib,  significantly reduced the risk of colon polyps during a trial  that was cut short after too many patients developed  cardiovascular problems. “For patients without major cardiovascular risk factors,  celecoxib at low doses protects against high-risk lesions that  can lead to colon cancer,” said Dr. Monica Bertagnolli,  associate professor of surgery at the Brigham and Women’s  Hospital, and the lead researcher on the Celebrex study. Meyskens said the combination therapy was likely to  eventually be used in people at high risk of colon cancer,  including those discovered to have advanced adenomas, as well  as patients diagnosed with low-stage colon cancer who have had  their disease cured. “About 30 to 35 percent of those patients will develop  another colon cancer,” he said. According to the American Cancer Society, colon cancer will  kill 52,000 people this year in the United States alone. Claim: Drug combination reduces colon cancer risk.

Answer:
Combining a low dose of a targeted  cancer-fighter with an anti-inflammatory drug reduces the risk  of recurring colorectal polyps, an early sign of colon cancer,  by as much as 95 percent, researchers said on Monday.